(Q40244012)

18 September 2017

title

A standardized ZAP-70 assay--lessons learned in the trenches (English)

1 reference

18 September 2017

1 reference

Keith E Shults

1

1 reference

18 September 2017

David T Miller

2

1 reference

18 September 2017

Bruce H Davis

3

1 reference

18 September 2017

Leanne Flye

4

1 reference

18 September 2017

Leigh Ann Hobbs

5

1 reference

18 September 2017

Gregory T Stelzer

6

1 reference

18 September 2017

publication date

1 July 2006

1 reference

Cytometry Part B: Clinical Cytometry

18 September 2017

published in

1 reference

18 September 2017

volume

70

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

276-283

1 reference

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

DNA histogram analysis for node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20136

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20136

1 reference

18 September 2017

1 reference